荟萃分析:轻至中度饮酒对进展性非酒精性脂肪性肝病的影响
该荟萃分析系统检索截至2022年11月的文献,纳入32篇横断面、病例对照和队列研究,评估轻至中度饮酒对进展性非酒精性脂肪性肝病(NAFLD)及死亡率的影响。队列研究报告中度饮酒增加进展性纤维化风险(合并OR 1.56;95%CI 1.08-2.26和HR 1.39;95%CI 1.22-1.57),但横断面研究未观察到该效应;饮酒还增加肝硬化和肝细胞癌风险,但似乎降低脂肪性肝炎风险;轻度饮酒对全因死亡率有保护作用,中度饮酒者中未观察到此效应。
要点
- 队列研究报告中度饮酒增加进展性纤维化风险(合并OR 1.56;95%CI 1.08-2.26和HR 1.39;95%CI 1.22-1.57)。
- 饮酒增加肝硬化和肝细胞癌风险,但似乎降低脂肪性肝炎风险。
- 轻度饮酒对全因死亡率有保护作用,中度饮酒者中未观察到此效应。
核心结论
- 关于饮酒对进展性NAFLD影响的研究存在广泛异质性。
- 队列研究报告中度饮酒对进展性纤维化的发生有显著有害效应。
- 需要进一步研究以就NAFLD患者的饮酒问题作出有效推荐。
研究设计与样本
- 系统检索Medline、Embase、OATD和OpenGrey截至2022年11月的相关横断面、病例对照和队列研究。
- 最终纳入32篇文章。
- 整个综述过程由两名独立审阅者完成。
- 对所有结局进行叙述性综合,并根据文章数量进行荟萃分析、亚组分析和发表偏倚评估。
主要发现
- 队列研究报告中度饮酒增加进展性纤维化风险(合并OR 1.56;95%CI 1.08-2.26和HR 1.39;95%CI 1.22-1.57),横断面研究未观察到该效应。
- 饮酒还增加肝硬化和肝细胞癌风险,但似乎降低脂肪性肝炎风险。
- 轻度饮酒对全因死亡率有保护作用,中度饮酒的NAFLD患者中未观察到此效应。
临床怎么用
- 原文未据此给出推荐。
- 作者指出需要进一步研究以就NAFLD患者的饮酒问题作出有效推荐。
局限性
- 关于饮酒对进展性NAFLD影响的研究存在广泛异质性。
- 需要进一步研究以就NAFLD患者的饮酒问题作出有效推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Non-alcoholic fatty liver disease (NAFLD) is defined as fatty liver disease in the absence of heavy alcohol consumption. However, the impact of light-to-moderate alcohol consumption on progressive NAFLD and on mortality is presently unclear. METHODS: Medline, Embase, OATD and OpenGrey were systematically searched up to November 2022 for relevant cross-sectional, case-control and cohort studies. The study outcomes were progressive NAFLD-steatohepatitis (NASH), fibrosis, cirrhosis, hepatocellular carcinoma (HCC) and mortality. The entire review process was performed by two independent reviewers. A narrative synthesis was performed for all outcomes, while meta-analyses, subgroup analyses and publication bias assessment were performed depending on the number of articles. RESULTS: After study selection, 32 articles were included. Cohort studies reported that moderate alcohol intake increased the risk for advanced fibrosis (pooled OR 1.56; 95% CI 1.08-2.26 and HR 1.39; 95% CI 1.22-1.57), which was not observed in cross-sectional studies. Alcohol use also increased the risk of developing liver cirrhosis and HCC, but seemed to lower the risk of steatohepatitis. Light alcohol consumption protected against all-cause mortality, an effect not observed in NAFLD patients with moderate intake. CONCLUSIONS: There is wide heterogeneity in studies on the impact of alcohol on progressive NAFLD. Nevertheless, cohort studies reported a significant harmful effect of moderate alcohol consumption on the occurrence of advanced fibrosis. Further research is needed to make valid recommendations with regard to alcohol consumption in patients with NAFLD.
引用
- Magherman L, Van Parys R, Pauwels NS, et al. Meta-analysis: The impact of light-to-moderate alcohol consumption on progressive non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2023. PMID: 36708129. doi:10.1111/apt.17388
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。